These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3334154)

  • 1. Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody.
    Valtonen MV; Kasper DL; Levy NJ
    Microb Pathog; 1986 Apr; 1(2):191-204. PubMed ID: 3334154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Rodewald AK; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1993 Nov; 61(11):4760-6. PubMed ID: 8406875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.
    Lachenauer CS; Madoff LC
    Infect Immun; 1996 Oct; 64(10):4255-60. PubMed ID: 8926097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.
    Gravekamp C; Horensky DS; Michel JL; Madoff LC
    Infect Immun; 1996 Sep; 64(9):3576-83. PubMed ID: 8751902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgG antibodies to carbohydrate and protein antigens in mouse protection tests with group B streptococci.
    Christensen KK; Christensen P; Duc G; Hitzig WH; Lindén V; Müller B; Seger RA
    Pediatr Res; 1984 May; 18(5):478-82. PubMed ID: 6203092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.
    Mavenyengwa RT; Maeland JA; Moyo SR
    Clin Vaccine Immunol; 2009 Sep; 16(9):1302-8. PubMed ID: 19587152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
    Madoff LC; Paoletti LC; Tai JY; Kasper DL
    J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity.
    Michel JL; Madoff LC; Kling DE; Kasper DL; Ausubel FM
    Infect Immun; 1991 Jun; 59(6):2023-8. PubMed ID: 1674738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse-protective antibodies against the Ibc proteins of group B streptococci.
    Bevanger L; Naess AI
    Acta Pathol Microbiol Immunol Scand B; 1985 Apr; 93(2):121-4. PubMed ID: 3893032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective levels of human immunoglobulin G antibody to group B streptococcus type Ib.
    Boyer KM; Kendall LS; Papierniak CK; Klegerman ME; Gotoff SP
    Infect Immun; 1984 Sep; 45(3):618-24. PubMed ID: 6381309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.
    Johnson DR; Ferrieri P
    J Clin Microbiol; 1984 Apr; 19(4):506-10. PubMed ID: 6201506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III.
    Stanton BF; Baltimore RS; Shedd DG
    Infect Immun; 1981 Jan; 31(1):391-5. PubMed ID: 7011999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci.
    Madoff LC; Michel JL; Kasper DL
    Infect Immun; 1991 Jan; 59(1):204-10. PubMed ID: 1702759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative R1 protein of Streptococcus agalactiae as serotype marker and target of protective antibodies.
    Moyo SR; Maeland JA; Lyng RV
    APMIS; 2001 Dec; 109(12):842-8. PubMed ID: 11846725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
    Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.
    Larsson C; Stålhammar-Carlemalm M; Lindahl G
    Vaccine; 1999 Feb; 17(5):454-8. PubMed ID: 10073723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological markers of the R4 protein of Streptococcus agalactiae.
    Maeland JA; Bevanger L; Lyng RV
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1305-10. PubMed ID: 16275945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ibc protein fraction of group B streptococci: characterization of protein antigens extracted by HCL.
    Bevanger L; Iversen J
    Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):205-9. PubMed ID: 7032201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
    Stålhammar-Carlemalm M; Stenberg L; Lindahl G
    J Exp Med; 1993 Jun; 177(6):1593-603. PubMed ID: 8496678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.